Opening Our Eyes To Stem Cells For Stargardt's Macular Dystrophy
Stem cell therapies are being studied in clinical trials to treat retinitis pigmentosa, a genetic disorder that causes vision loss.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
More News: Clinical Trials | Eyes | Genetics | Pharmaceuticals | Reflex Sympathetic Dystrophy | Retinitis Pigmentosa | Stem Cell Therapy | Stem Cells